NOVOSIMILAR
cells for medical or clinical use; pharmaceuticals, medicines, biologics, biotherapeutics, therapeutics, and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejection, inflammatory diseases, and life-threatening diseases; pharmaceutical and biopharmaceutical preparations for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejection, inflammatory diseases, and life-threatening diseases; pharmaceutical, m...
Abandoned · July 23, 2018 · 88048619 ·